Related Experiment Video
Updated: Feb 12, 2026

Renal Subcapsular Transplantation of 2'-Deoxyguanosine-Treated Murine Embryonic Thymus in Nude Mice
Published on: July 19, 2019
Patient and transplant outcome in infants starting renal replacement therapy before 2 years of age
Julien Hogan1,2, Justine Bacchetta3, Marina Charbit4
1Pediatric Nephrology Department, Robert Debré University Hospital, APHP, Paris, France.
Insights
Children needing renal replacement therapy (RRT) before age two have good survival rates. Extrarenal comorbidities increase mortality risk, while optimal donor matching improves graft survival post-transplantation.
Area of Science:
- Pediatric Nephrology
- Renal Replacement Therapy
- Organ Transplantation
Background:
- Management of children requiring renal replacement therapy (RRT) before two years of age presents challenges.
- Transplantation is often delayed until children reach 10 kg or two years old.
- This study addresses patient and graft survival in this pediatric population.
Purpose of the Study:
- To evaluate patient and graft survival in children initiating RRT before 24 months of age.
- To provide data to guide RRT initiation and transplantation management decisions for young children.
- To identify factors influencing survival and transplantation outcomes in this cohort.
Main Methods:
- A national cohort study included children starting RRT before 24 months of age between 1992 and 2012 in France.
- Data were collected through the national Renal Epidemiology and Information Network (REIN) registry.
- Primary endpoints were patient survival on dialysis and 10-year graft survival.
Main Results:
- The 10-year survival rate for the 224 included children was 84%.
- Extrarenal comorbidities were associated with increased mortality risk on dialysis and reduced transplantation probability.
- 10-year graft survival was 74%, with factors like time on dialysis, donor/recipient height mismatch, and HLA-DR mismatches impacting graft loss.
Conclusions:
- Children starting RRT before two years of age demonstrate good outcomes.
- Optimal timing and methods for transplantation in this group require careful consideration.
- Findings offer data on morphological and immunological matching to aid clinical decision-making.
Background:
Despite major technical improvements in the care of children requiring renal replacement therapy (RRT) before 2 years of age, the management of those patients remains challenging and transplantation is generally delayed until the child weighs 10 kg or is 2 years old. In this national cohort study, we studied patient and graft survival in children starting RRT before 2 years of age to help clinicians and parents when deciding on RRT initiation and transplantation management.
Methods:
All children starting RRT before 24 months of age between 1992 and 2012 in France were included through the national Renal Epidemiology and Information Network (REIN) registry. The primary endpoints were patient survival on dialysis and 10-year graft survival.
Results:
A total of 224 patients were included {62% boys, median age 10.5 months [interquartile range (IQR) 5.8-15.6]}. The 10-year survival rate was 84% (IQR 77-89). Suffering from extrarenal comorbidities was the only factor significantly associated with both an increased risk of death on dialysis [hazard ratio 5.9 (95% confidence interval 1.8-19.3)] and a decreased probability of being transplanted. During follow-up, 174 renal transplantations were performed in 171 patients [median age at first transplantation 30.2 (IQR 21.8-40.7) months]. The 10-year graft survival was 74% (IQR 67-81). Factors associated with graft loss in multivariate analysis were the time spent on dialysis before transplantation, donor/recipient height ratio with an increased risk for both small and tall donors and presenting two human leucocyte antigen-antigen D-related mismatches.
Conclusions:
This study confirms the good outcome of children starting RRT before 2 years of age. The main question remains when and how to transplant those children. Our study provides data on the optimal morphological and immunological matching in order to help clinicians in their decisions.
Related Concept Videos
Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Pharmacodynamics in Geriatric Patients: Effects of Age
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

